Articolo su Rivista: [35263] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 20.121 a 20.140 di 35.263
Titolo Data di pubblicazione Autore(i) File
Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease 1-gen-2007 Arcaini, L; Paulli, M; Burcheri, S; Rossi, A; Spina, M; Passamonti, Francesco; Lucioni, M; Motta, T; Canzonieri, V; Montanari, M; Bonoldi, E; Gallamini, A; Uziel, L; Crugnola, M; Ramponi, A; Montanari, F; Pascutto, C; Morra, E; Lazzarino, M.
Blast phase of essential thrombocythemia: A single center study. 1-gen-2009 Passamonti, Francesco; Rumi, E; Arcaini, L; Elena, C; Castagnola, C; Zappasodi, P; Bernasconi, P; Pietra, D; Pascutto, C; Cazzola, M; Lazzarino, M.
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas. 1-gen-2010 Arcaini, L; Merli, M; Passamonti, Francesco; Bruno, R; Ebrusamolino, E; Sacchi, P; Rattotti, S; Orlandi, E; Rumi, E; Ferretti, V; Rizzi, S; Meli, E; Pascutto, C; Paulli, M; Lazzarino, M.
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection 1-gen-2009 Arcaini, L; Pascutto, C; Passamonti, Francesco; Bruno, R; Merli, M; Rizzi, S; Orlandi, E; Astori, C; Rattotti, S; Paulli, M; Lazzarino, M.
Myelofibrotic transformation in essentialthrombocythemia. Author reply 1-gen-2009 Passamonti, Francesco; Rumi, E.; Boveri, E.; Lazzarino, M.
Immunochemotherapy with rituximab, vincristine and 5-days cyclophosphamide (R-CV) for heavily pretreated follicular lymphoma 1-gen-2005 Lazzarino, M; Arcaini, L; Orlandi, E; Iacona, I; Bernasconi, P; Calatroni, S; Varettoni, M; Isa, L; Brusamolino, E; Bonfichi, M; Passamonti, Francesco; Burcheri, S; Pascutto, C; Regazzi, M.
Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman. 1-gen-2004 Passamonti, Francesco; Rumi, E; Malabarba, L; Arcaini, L; Orlandi, E; Brusamolino, E; Pascutto, C; Cazzola, M; Lazzarino, M.
Orthogonal polynomials of equilibrium measures supported on Cantor sets 1-gen-2015 Mantica, GIORGIO DOMENICO PIO
Refinable functions, functionals, and iterated function systems 1-gen-2016 Calabrò, F.; Corbo Esposito, A.; Mantica, GIORGIO DOMENICO PIO; Radice, T.
Low mean impedance in 24-hour tracings and esophagitis in children: a strong connection 1-gen-2016 Salvatore, Silvia; Salvatoni, Alessandro; Ummarino, D; Ghanma, A; Van der Pol, R; Rongen, A; Fuoti, M; Meneghin, F; Benninga, Ma; Vandenplas, Y.
The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients. 1-gen-2011 Scherber, R; Dueck, Ac; Johansson, P; Barbui, T; Barosi, G; Vannucchi, Am; Passamonti, Francesco; Andreasson, B; Ferarri, Ml; Rambaldi, A; Samuelsson, J; Birgegard, G; Tefferi, A; Harrison, Cn; Radia, D; Mesa, R. A.
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients. 1-gen-2011 Carobbio, A; Thiele, J; Passamonti, Francesco; Rumi, E; Ruggeri, M; Rodeghiero, F; Randi, Ml; Bertozzi, I; Vannucchi, Am; Antonioli, E; Gisslinger, H; Buxhofer Ausch, V; Finazzi, G; Gangat, N; Tefferi, A; Barbui, T.
Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression 1-gen-2011 Klampfl, T; Harutyunyan, A; Berg, T; Gisslinger, B; Schalling, M; Bagienski, K; Olcaydu, D; Passamonti, Francesco; Rumi, E; Pietra, D; Jäger, R; Pieri, L; Guglielmelli, P; Iacobucci, I; Martinelli, G; Cazzola, M; Vannucchi, Am; Gisslinger, H; Kralovics, R.
Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSS. 1-gen-2011 Elena, C; Passamonti, Francesco; Rumi, E; Malcovati, L; Arcaini, L; Boveri, E; Merli, M; Pietra, D; Pascutto, C; Lazzarino, M.
European LeukemiaNet. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet. 1-gen-2011 Barbui, T; Barosi, G; Birgegard, G; Cervantes, F; Finazzi, G; Griesshammer, M; Harrison, C; Hasselbalch, Hc; Hehlmann, R; Hoffman, R; Kiladjian, Jj; Kröger, N; Mesa, R; Mcmullin, Mf; Pardanani, A; Passamonti, Francesco; Vannucchi, Am; Reiter, A; Silver, Rt; Verstovsek, S; Tefferi, A.
JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations. 1-gen-2011 Pardanani, A; Vannucchi, Am; Passamonti, Francesco; Cervantes, F; Barbui, T; Tefferi, A.
Prognostic factors and models in polycythemia vera, essential thrombocythemia, and primary myelofibrosis 1-gen-2011 Passamonti, Francesco
Myeloproliferative neoplasms: from JAK2 mutations discovery to JAK2 inhibitor therapies 1-gen-2011 Passamonti, Francesco; Maffioli, M; Caramazza, D; Cazzola, M.
What are RBC-transfusion-dependence and -independence? 1-gen-2011 Gale, Rp; Barosi, G; Barbui, T; Cervantes, F; Dohner, K; Dupriez, B; Gupta, V; Harrison, C; Hoffman, R; Kiladjian, Jj; Mesa, R; Mc Mullin, Mf; Passamonti, Francesco; Ribrag, V; Roboz, G; Saglio, G; Vannucchi, A; Verstovsek, S.
Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasms. 1-gen-2011 Elena, C; Rumi, E; Portolan, M; Della Porta, Mg; Pascutto, C; Passamonti, Francesco
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 20.121 a 20.140 di 35.263
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • Articoli su Riviste35263
Autore
  • AGENO, WALTER690
  • IACOVIELLO, LICIA598
  • GHEZZI, FABIO505
  • DENTALI, FRANCESCO465
  • ANGELI, FABIO383
  • CASTELNUOVO, PAOLO GIOCONDO MARIA378
  • PIFFARETTI, GABRIELE369
  • PREST, MICHELA357
  • MASCIOCCHI, NORBERTO352
  • DIONIGI, GIANLORENZO340
Data di pubblicazione
  • In corso di stampa26
  • 2020 - 202710432
  • 2010 - 201911845
  • 2000 - 20097910
  • 1990 - 19993628
  • 1980 - 19891162
  • 1970 - 1979252
  • 1967 - 19698
Editore
  • Edizioni Luigi Pozzi Srl:via Pana...51
  • Japadre Editore, L'Aquila36
  • WILEY34
  • Elsevier BV:PO Box 211, 1000 AE A...31
  • ELSEVIER SCIENCE BV29
  • Franco Angeli Riviste SRL:viale M...28
  • Springer Verlag Germany:Tiergarte...28
  • -Roma: [s.n.]. -Artegierre-Esseze...26
  • Elsevier B.V.23
  • Royal Society of Chemistry:Thomas...21
Rivista
  • PHYSICAL REVIEW LETTERS216
  • LA RADIOLOGIA MEDICA180
  • NUCLEAR INSTRUMENTS & METHODS IN ...176
  • ASTRONOMY & ASTROPHYSICS168
  • MONTHLY NOTICES OF THE ROYAL ASTR...165
  • PLOS ONE163
  • PHYSICS LETTERS. SECTION B154
  • SCIENTIFIC REPORTS153
  • THROMBOSIS AND HAEMOSTASIS145
  • IL PROTAGORA140
Serie
  • PROCEEDINGS OF INTERNATIONAL MATH...1
Keyword
  • Humans1627
  • Female817
  • Male695
  • Middle Aged526
  • COVID-19518
  • Aged481
  • Adult464
  • Italy345
  • SARS-CoV-2317
  • Treatment Outcome240
Lingua
  • eng18885
  • ita2906
  • fre60
  • spa55
  • ger35
  • por14
  • bul9
  • rus8
  • gre6
  • chi3
Accesso al fulltext
  • no fulltext24730
  • reserved5245
  • open5085
  • restricted107
  • partially open93
  • mixed2
  • embargoed1